-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTIS LABS RAISES US$25 MILLION SERIES A CO-LED BY ORBIMED AND QIMING VENTURE PARTNERS USA TO ACCELERATE CLINICAL DEVELOPMENT WITH AI ENDPOINTS

Reuters·09/17/2026 11:00:44

Please log in to view news